<DOC id="CNA_ENG_20041218.0010" type="multi" >
<HEADLINE>
INTERNATIONAL HEADLINE NEWS
</HEADLINE>
<DATELINE>
Washington, Dec. 18 (CNA)
(By Jorge Liu)
</DATELINE>
<TEXT>
The Washington Post: Celebrex Trial
Halted After Finding Of Heart Risk; Similar Side Effects Led To
Withdrawal of Vioxx.

A clinical trial of the blockbuster arthritis drug Celebrex was
shut down yesterday after researchers found an increase in the risk
of serious heart disease and strokes in those taking the drug, the
same side effects that caused the related painkiller Vioxx to be
taken off the market this fall.
</TEXT>
</DOC>
